Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.048B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.720B 17.89
Encompass Health (EHC) United States $11.099B 23.53
DaVita (DVA) United States $10.598B 14.90
Elanco Animal Health (ELAN) United States $6.794B 14.55
Chemed (CHE) United States $6.032B 20.12
Option Care Health (OPCH) United States $4.763B 20.38
RadNet (RDNT) United States $4.106B 260.62
Amedisys (AMED) United States $3.243B 20.76
Addus HomeCare (ADUS) United States $1.965B 21.57
LifeStance Health (LFST) United States $1.548B 0.00
Astrana Health (ASTH) United States $1.338B 33.14
U.S Physical Therapy (USPH) United States $1.111B 28.69
Atai Life Sciences (ATAI) Germany $0.821B 0.00
Aveanna Healthcare Holdings (AVAH) United States $0.775B 44.11
Pennant (PNTG) United States $0.764B 28.06
MEDIROM Healthcare Technologies (MRM) Japan $0.034B 0.00
Ontrak (OTRK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00